Lipopolysaccharide‐induced kidney dysfunction via NF‐κB and MAPK activation, by excessive production of IL‐6, TNF‐α, iNOS, and COX‐2, producing perturbance in energy metabolism and oxidative stress. Here, PTGS2 is linked to medical procedure.